PRE: Prenetics Global Ltd Price to Sales

Brandmark of Prenetics Global Ltd (PRE)

Danny Young's rapid expansion creates certain operational risks; however, the revenue multiple dynamics on the GURU.Markets intraday chart, where the current value is 1.80, confirm the asset's stability. Prenetics Global (PRE) maintains its leadership in Asian DNA screening, and its pivot toward early cancer diagnostics supported by liquid partnerships neutralizes volatility, strengthening its status as a global player in personalized medicine.

PRE (Prenetics Global) P/S Multiple history from 04/28/2023 to 11/13/2026

Analytical breakdowns for Prenetics Global (PRE)

- share price and consensus valuation forecast:
Price Performance Chart prenetics.com|PRE - Analyst Consensus Forecast
- market capitalization information:
Market Value Prenetics Global Ltd|PRE - Total Company Value
- shareholders' equity book value data:
Equity per Share Prenetics|PRE - Book Capitalization|Market-to-Book Ratio prenetics.com|PRE - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Aggregate Debt to Capital Prenetics Global|PRE - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient prenetics.com|PRE - Company Aggregate Debts|Debt to Book Value Prenetics Global Ltd|PRE - Company Long-Term Debt|Short-Term Debt Volume Prenetics|Intermediate Coverage Ratio prenetics.com
- net income and valuation multiples indicators:
PRE - Net Profit|Projected Net Profit Prenetics Global|PRE - Price to Earnings Ratio|Future Price to Earnings prenetics.com|PRE - Price/Earnings to Growth Ratio|Company Value to EBITDA Prenetics Global Ltd|PRE - Operating profit EBITDA|Earnings per share for the last twelve months Prenetics|PRE - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth prenetics.com|PRE - Earnings per share growth in current year|Net earnings per share growth forecast for next year Prenetics Global
- issuer revenue and sales details:
PRE - Company Revenue|Company Expected Revenue prenetics.com|PRE - Price-to-Revenue Ratio|Forward Price to Sales Prenetics Global Ltd
General company analysis:PRE (Prenetics Global Limited)
Brand item of Prenetics Global Limited

The P/S ratio reflects the market value of every dollar of sales for Prenetics Global (PRE), allowing for an assessment of the asset's overbought status relative to historical medians. By analyzing the price-to-sales-per-share ratio, an investor can compare current capitalization with the efficiency of optimized diagnostic system logistics to avoid purchasing the security at the peak of a speculative bubble and prevent deep drawdowns.

Competitors of Prenetics Global

A (agilent.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple DGX (Quest Diagnostics Incorporated)|Illumina Inc (ILMN) - Price to Sales|EXAS - Price-to-Revenue Ratio|RVTY (Revvity Corp) - Market Cap to Revenue Ratio|BIO: P/S Multiple|Price to Sales anbio.com (NNNN)|Market Cap to Revenue SHC|QDEL (Quidel Corporation) - Market Cap to Sales Volume|P/S Multiple OPK|Price-to-Revenue Coefficient CareDx Health|P/S Multiple MRVI (Maravai LifeSciences)|FLGT - Market Cap to Revenue|LAB - Price-to-Revenue Ratio|Price-to-Revenue Coefficient Cytek Biosciences Inc CTKB|OSUR (OraSure Technologies Inc) - Market Cap to Revenue|Exagen - Market Capitalization-to-Revenue Ratio|MDXH (MDxHealth SA) - P/S Multiple|LUCD - Price-to-Revenue Multiple|Price-to-Revenue Ratio Insight Molecular Diagnostics (IMDX)|Price-to-Revenue Ratio TRIB (trinitybiotech.com)|Price-to-Revenue Ratio ProPhase PRPH|Ainos Corporation (AIMD) - Price to Sales|Co-Diagnostics, Inc. - P/S Multiple|HSCS: Price-to-Revenue Ratio|BMRA: P/S Multiple|Cardio Diagnostics Holdings (CDIO) - P/S Multiple|Price-to-Revenue Ratio Onconetix Corp|Price-to-Revenue Ratio VRAX|Price-to-Revenue Ratio Bluejay Diagnostics (BJDX)|AWH: Price-to-Sales Ratio|Price-to-Revenue Ratio Accelerate Diagnostics, Inc. AXDX|Market Capitalization-to-Revenue Ratio CNTG|Enzo - P/S Multiple|Price to Sales Fresh2 Group Limited|gtglabs.com (GENE) - Price-to-Revenue Ratio|Market Cap to Revenue 23andme.com|PMD (Psychemedics Corporation) - P/S Multiple